Decisive Consulting is a global Market Access consultancy, created in 2020 as a solution to a gap our founder, Esther Nzenza, saw during her 24 years in the pharmaceutical industry.

Our aim is to create fair access for patients in life sciences, through the belief that access is everyone’s business. ​

With an access-first lens, we bring the CURIOSITY, CAPABILITY and CAPACITY that life sciences companies need at DECISIVE MOMENTS of their evolution.​ We provide not just ideas and plans, but active support where it’s needed to harness REBEL THINKING for better decisions​.

Our experienced team have worked in industry leadership roles, on average for 20 years+. We are proficient at identifying what needs to be achieved, and make sure it delivered, we lean-in where other consultancies step back.

We serve a variety of clients ranging from global pharmaceutical companies to emerging biotech organisations at all stages of development, from early concepts through to in-country P&R negotiation:

Strategic Planning throughout lifecycle
Market Access and Pricing Strategy & Execution
Launch sequencing
Commercial Assessments

We help you find the weaknesses in your cross functional plans and devise ways to address them:

Gap analysis and mitigation planning
Launch Readiness Reviews
Mock Payer Negotiations
Advisory Boards and targeted insight gathering
JCA readiness (PICO)

https://teamdecisive.com/
https://www.picopredict.com/